BR0111428A - Combinações de eter carboxialquìlico e inibidor de acat - Google Patents
Combinações de eter carboxialquìlico e inibidor de acatInfo
- Publication number
- BR0111428A BR0111428A BR0111428-0A BR0111428A BR0111428A BR 0111428 A BR0111428 A BR 0111428A BR 0111428 A BR0111428 A BR 0111428A BR 0111428 A BR0111428 A BR 0111428A
- Authority
- BR
- Brazil
- Prior art keywords
- acat inhibitor
- combinations
- ether
- carboxyalkyl
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21005600P | 2000-06-07 | 2000-06-07 | |
PCT/US2001/014804 WO2001093845A2 (en) | 2000-06-07 | 2001-05-08 | Carboxyalkylether-acat inhibitor combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0111428A true BR0111428A (pt) | 2003-06-10 |
Family
ID=22781424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0111428-0A BR0111428A (pt) | 2000-06-07 | 2001-05-08 | Combinações de eter carboxialquìlico e inibidor de acat |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1292363A2 (es) |
JP (1) | JP2003535125A (es) |
AR (1) | AR034255A1 (es) |
AU (1) | AU2001263003A1 (es) |
BR (1) | BR0111428A (es) |
CA (1) | CA2413906A1 (es) |
GT (1) | GT200100106A (es) |
MX (1) | MXPA02010762A (es) |
PA (1) | PA8518601A1 (es) |
PE (1) | PE20020265A1 (es) |
SV (1) | SV2002000466A (es) |
TN (1) | TNSN01085A1 (es) |
UY (1) | UY26752A1 (es) |
WO (1) | WO2001093845A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7387236B2 (en) | 2001-10-09 | 2008-06-17 | Delaware Capital Formation, Inc. | Dispensing of currency |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE320803T1 (de) * | 1998-01-28 | 2006-04-15 | Warner Lambert Co | Verfahren zur behandlung von alzheimerschen krankheit |
-
2001
- 2001-05-08 WO PCT/US2001/014804 patent/WO2001093845A2/en active Application Filing
- 2001-05-08 CA CA002413906A patent/CA2413906A1/en not_active Abandoned
- 2001-05-08 BR BR0111428-0A patent/BR0111428A/pt not_active IP Right Cessation
- 2001-05-08 EP EP01937250A patent/EP1292363A2/en not_active Withdrawn
- 2001-05-08 JP JP2002501418A patent/JP2003535125A/ja active Pending
- 2001-05-08 AU AU2001263003A patent/AU2001263003A1/en not_active Abandoned
- 2001-05-08 MX MXPA02010762A patent/MXPA02010762A/es not_active Application Discontinuation
- 2001-05-24 SV SV2001000466A patent/SV2002000466A/es not_active Application Discontinuation
- 2001-06-05 TN TNTNSN01085A patent/TNSN01085A1/en unknown
- 2001-06-05 UY UY26752A patent/UY26752A1/es not_active Application Discontinuation
- 2001-06-05 PA PA20018518601A patent/PA8518601A1/es unknown
- 2001-06-05 PE PE2001000517A patent/PE20020265A1/es not_active Application Discontinuation
- 2001-06-05 GT GT200100106A patent/GT200100106A/es unknown
- 2001-06-06 AR ARP010102688A patent/AR034255A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1292363A2 (en) | 2003-03-19 |
JP2003535125A (ja) | 2003-11-25 |
SV2002000466A (es) | 2002-04-03 |
MXPA02010762A (es) | 2003-03-10 |
TNSN01085A1 (en) | 2005-11-10 |
WO2001093845A2 (en) | 2001-12-13 |
CA2413906A1 (en) | 2001-12-13 |
AR034255A1 (es) | 2004-02-18 |
GT200100106A (es) | 2002-05-20 |
WO2001093845A3 (en) | 2002-10-10 |
UY26752A1 (es) | 2001-07-31 |
PE20020265A1 (es) | 2002-04-19 |
AU2001263003A1 (en) | 2001-12-17 |
PA8518601A1 (es) | 2002-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG105428A (en) | 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors | |
MY121405A (en) | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines | |
EP1163208A4 (en) | CASPASE INHIBITORS AND THEIR USE | |
BR9907300A (pt) | Inibidores do fator xa oxoaza-heterociclila substituìdos | |
BR0209064A (pt) | Hidroxamatos de alquila tricìclicos, sua preparaçãoe seu uso como inibidores de proliferação de células | |
MX2007004783A (es) | Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan. | |
EA200200858A1 (ru) | Фармацевтические композиции, содержащие ингибиторы гликогенфосфорилазы | |
AR029383A1 (es) | Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes | |
MA29746B1 (fr) | Nouveaux inhibiteurs macrocycliques de la multiplication du virus de l'hepatite c | |
ES2193874A1 (es) | Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas. | |
YU18999A (sh) | Supstituisani tricikli | |
BRPI0408897A (pt) | derivados de 1,2,3,4-tetrahidro-e 1,2-dihidro-quinolina 1,2,4-substituìdos como inibidores de cetp para o tratamento de arteroesclerose e obesidade | |
MA30272B1 (fr) | Derives de dibenzylamines servant d'inhibiteurs de cetp. | |
MX2007003441A (es) | Compuestos de 4-amino-sustituido-2-sustituido-1,2,3,4- tetrahidroquinolina. | |
BR0111428A (pt) | Combinações de eter carboxialquìlico e inibidor de acat | |
ITMI20042475A1 (it) | Uso di derivati tiazolidinonici come agenti terapeutici | |
BR0309009A (pt) | Método para o tratamento de hipersecreção de muco | |
BR0009214A (pt) | Composições aquosas estáveis contendo umcomposto de silìcio | |
ATE198323T1 (de) | Diphenylstibene als prodrugs zu cox-2-inhibitoren | |
PT1292290E (pt) | Composicoes farmaceuticas que compreendem derivados de acriloil-distamicina e inibidores de topoisomerase 1 e ii | |
IL113706A (en) | N-hydroxyurea alkyl phenyl oxazoles and thiazoles uses thereof as anti-inflammatory agents and pharmaceutical compositions containing them | |
DK0966462T3 (da) | Heterocykliske forbindelser, der er egnede som oxidosqualencyklaseinhibitorer | |
BR0211425A (pt) | Método para a preparação de compostos, e, uso de uma composição | |
BR0214241A (pt) | Método para preparar uma composição compreendendo lipossomas contendo anestésico tópico e composição obtida | |
BR0107204A (pt) | Inibidores da angiogênese de hidrazida e alcoxiamida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009. |